Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2010-023945-31Phase 2Completed
Phase 2, randomised trial of prasugrel in asthma (2 arms), sponsored by ASST Santi Paolo e Carlo. Primary endpoint: Bronchial hyperresponsiveness to mannitol. Started Mar 2012; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2010-023945-31.